Literature DB >> 15339364

Understanding access to genitourinary medicine services.

V Griffiths1, I Ahmed-Jushuf, J A Cassell.   

Abstract

In this study we describe waiting times in genitourinary medicine clinics (England, Wales, Northern Ireland), describe patterns of clinic attendance over time, and explore the association between waiting times and attendance patterns. A postal survey of clinicians in October 2002 explored waiting times and appointment policy. Clinic attendance data were linked to survey responses, and attendance trends described in relation to national sexually transmitted infection (STI) data. Waiting times were reported, and associations between attendance patterns and appointment policy explored. Mean waiting times were 11.2 days for males and 12.5 days for females. An association between longer waiting time and new males' non-attendance rates was shown. From 1996 to 2002 there was no overall increase in attendances in English clinics, while the proportion of all patients who were new or had a new problem increased from 0.37 to 0.44, and the ratio of new STI diagnoses to new attenders increased from 0.2 to 0.31. Major acute STIs diagnosed in England increased from 114,380 to 185,247 cases.

Entities:  

Mesh:

Year:  2004        PMID: 15339364     DOI: 10.1258/0956462041724280

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  9 in total

1.  Public involvement in modernising genitourinary medicine clinics: using general public and patient opinion to influence models of service delivery.

Authors:  J D C Ross; A Copas; J Stephenson; L Fellows; G Gilleran
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

2.  Improving sexual health services in the city: can the NHS learn from clients and the service industry.

Authors:  Hitesh Patel; Juan Baeza; Mitesh Patel; Linda Greene; Nick Theobald
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

3.  A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations.

Authors:  Mark I Chen; Azra C Ghani; W John Edmunds
Journal:  J R Soc Interface       Date:  2008-11-04       Impact factor: 4.118

4.  Texting decreases the time to treatment for genital Chlamydia trachomatis infection.

Authors:  A S Menon-Johansson; F McNaught; S Mandalia; A K Sullivan
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

5.  Supply and demand: estimating the real need for care while meeting the 48 hour waiting time target in a genitourinary medicine clinic by a closed appointment system.

Authors:  J Clarke; H Christodoulides; Y Taylor
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

6.  Assessing user preferences for sexually transmitted infection testing services: a discrete choice experiment.

Authors:  Alec Miners; Carrie Llewellyn; Alex Pollard; Mylene Lagarde; Daniel Richardson; John Cairns; Martin Fisher; Helen Smith
Journal:  Sex Transm Infect       Date:  2012-06-01       Impact factor: 3.519

7.  Identifying outbreaks of sexually transmitted infection: who cares?

Authors:  Dirk Werber; Meirion R Evans; Daniel Rh Thomas
Journal:  BMC Public Health       Date:  2006-10-24       Impact factor: 3.295

8.  A tale of three cities: persisting high HIV prevalence, risk behaviour and undiagnosed infection in community samples of men who have sex with men.

Authors:  Julie P Dodds; Anne M Johnson; John V Parry; Danielle E Mercey
Journal:  Sex Transm Infect       Date:  2007-05-01       Impact factor: 3.519

9.  How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs?

Authors:  Catherine H Mercer; Lorna Sutcliffe; Anne M Johnson; Peter J White; Gary Brook; Jonathan D C Ross; Jyoti Dhar; Paddy Horner; Frances Keane; Eva Jungmann; John Sweeney; George Kinghorn; Geoff G Garnett; Judith M Stephenson; Jackie A Cassell
Journal:  Sex Transm Infect       Date:  2007-05-02       Impact factor: 3.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.